Advertisement

Topics

Cerenis Therapeutics: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital

12:31 EST 14 Nov 2017 | FinanzNachrichten

Article L233-8-II of the French Commercial CodeArticle 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: Cerenis Therapeutics (Paris:CEREN): Market...

Original Article: Cerenis Therapeutics: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital

NEXT ARTICLE

More From BioPortfolio on "Cerenis Therapeutics: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital"

Advertisement
Quick Search
Advertisement
Advertisement